Breaking: Pfizer in hot pursuit of a $5B buyout of Global Blood Therapeutics — report

Pfizer CEO Albert Bourla has vowed to leave no stone unturned in the search for new biotech deals, and the BD team is not letting him down. The Wall Street Journal reported today that Pfizer is in the final stages of acquiring Global Blood Therapeutics for $5 billion. According to…

Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.


*